• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA clears Shimadzu hybrid CT

Article

Shimadzu Medical Systems has highhopes for its new SCT-4800 line of CT scanners. The vendor hasalready sold 10 systems in the U.S. since the Food and Drug Administrationcleared the line in July. Shimadzu is targeting sales of 40 systemsin the U.S. and

Shimadzu Medical Systems has highhopes for its new SCT-4800 line of CT scanners. The vendor hasalready sold 10 systems in the U.S. since the Food and Drug Administrationcleared the line in July. Shimadzu is targeting sales of 40 systemsin the U.S. and 400 worldwide by March 1995, according to DonKarle, marketing manager of CT and MRI for the Torrance, CA-basedvendor.

Shimadzu unveiled the SCT-4800 series at last year's RadiologicalSociety of North America conference (SCAN 11/17/94). The seriesincludes SCT-4800TF, a higher end scanner, and SCT-4800TE. Bothsystems are non-spiral scanners and list below $500,000.

The 4800 line is unique in that its x-ray generator can powerboth the CT scanner and a radiographic room. This is an addedplus in developing countries such as those in southeast Asia,according to Karle. The scanners are marketed outside the U.S.as Intellect FXT and Intellect EXT.

In other Shimadzu news, MRI director Mark Silverman has leftthe company. Silverman was brought on in an attempt to jump-startShimadzu's MRI effort (SCAN 7/28/93). Shimadzu decided to scaleback its MRI sales program earlier this year, and Silverman waslet go as part of that restructuring (SCAN 7/13/94). Karle willassume Silverman's responsibilities.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.